Facebook Twitter YouTube Flickr Instagram LinkedIn

Our Mission
Our Impact
Patients & Caregivers
Research
Your Voice
Events
Take Action
Donate

Clinical Trial Finder

Filters

Keyword

You can narrow your results further by searching each trial’s description for a specific word. Keep in mind that this will search the full description. We recommend carefully reviewing each trial information to ensure that it is an appropriate fit for you.

Astrocytoma

Diffuse Intrinsic Pontine Glioma

Ependymoma

Glioblastoma

Meningioma

Oligodendroglioma

Newly Diagnosed

Recurrent

Metastatic

Zip code

Distance radius

Age

Gender

Male

Female

Patient status?

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

I have a brain tumor

I am a healthy volunteer

Type of trial?

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.

Searching Both is inclusive of interventional and observational studies.

Both

Observational

Interventional

Phase?

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

2301 - 2302 of 2302 Trials

IFx-Hu2.0 Expanded Access Program

Expanded access requests for IFx-Hu2.0 may be considered for the treatment of adult patients (greater than or equal to 18 years of age) with stage III through IV cutaneous melanoma, advanced Merkel cell carcinoma (MCC), or advanced cutaneous squamous cell carcinoma (cSCC) who have failed all available treatment options. To request access, use Responsible Party contact information provided in this record.

18 Years and Over
Available

Learn More
Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

This is an intermediate-size expanded access protocol to provide ONC201 to patients with H3 K27M-mutant and/or midline gliomas who cannot access ONC201 through clinical trials.

2 Years and Over
Available

Learn More

← Previous 1 … 225 226 227 228 229 230 231 Next →

The content provided by NBTS on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation. For a full description of terms please refer to: Terms, Conditions & Privacy

Search By Connection:

Patients & Families Advocates Supporters Researchers Industry Media

Brain Tumor Info
About us
Advance research
Advocate for Issues
Join the Fight

Donate

Terms Privacy Copyright

Facebook Twitter YouTube Flickr

Questions to Ask Your Doctor about Treatment Clinical Trials

If you are thinking about taking part in a clinical trial, be sure to ask your doctor, “Is there a clinical trial that I can join?” If your doctor offers you a trial, here are some questions you may want to ask.

Questions about the Trial

What is the purpose of the trial?
Why do the researchers believe that the treatment being studied may be better than the one being used now? Why may it not be better?
How long will I be in the trial?
What kinds of tests and treatments are involved?
How will the doctor know if the treatment is working?
How will I be told about the trial’s results?
How long do I have to make up my mind about joining this trial?
Who can I speak with about questions I have during and after the trial?
Who will be in charge of my care?
Is there someone I can talk to who has been in the trial?

Questions about Risks and Benefits

What are the possible side effects or risks of the new treatment?
What are the possible benefits?
How do the possible risks and benefits of this trial compare to those of the standard treatment?

Questions about Your Rights

How will my health information be kept private?
What happens if I decide to leave the trial?

Questions about Costs

Will I have to pay for any of the treatments or tests?
What costs will my health insurance cover?
Who pays if I’m injured in the trial?
Who can help answer any questions from my insurance company?

Questions about Daily Life

How could the trial affect my daily life?
How often will I have to come to the hospital or clinic?
Will I have to stay in the hospital during the clinical trial? If so, how often and for how long?
Will I have to travel long distances?
Will I have check-ups after the trial?

Questions about Comparing Choices

What are my other treatment choices, including standard treatments?
How does the treatment I would receive in this trial compare with the other treatment choices?
What will happen to my cancer without treatment?

Understanding Clinical Trials Video Playlist

Please enable Javacsript to view this content

Related Resources

If You Want to Find Ways to Prevent Cancer...Learn About Prevention Clinical Trials
Taking Part in Cancer Treatment Research Studies
Providing Your Tissue for Research: What You Need To Know
Cancer Clinical Trials at the National Institutes of Health Clinical Center
Steps to Find a Clinical Trial
Organizations That Offer Support Services

Posted: Tue, 09/11/2012 - 12:00

Updated: Fri, 11/02/2012 - 12:00

Reviewed: Wed, 02/12/2020 - 12:00

This content is provided by the National Cancer Institute (www.cancer.gov)

Syndicated Content Details:
Source URL: https://www.cancer.gov/node/420505/syndication
Source Agency: National Cancer Institute (NCI)
Captured Date: 2018-08-08 17:10:14.0

IFx-Hu2.0 Expanded Access Program

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas